WO2008129607A1 - ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 - Google Patents
ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 Download PDFInfo
- Publication number
- WO2008129607A1 WO2008129607A1 PCT/JP2007/057741 JP2007057741W WO2008129607A1 WO 2008129607 A1 WO2008129607 A1 WO 2008129607A1 JP 2007057741 W JP2007057741 W JP 2007057741W WO 2008129607 A1 WO2008129607 A1 WO 2008129607A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronan
- production accelerator
- suppressant
- decomposition
- decomposition suppressant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
- C07H7/033—Uronic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【課題】ヒアルロナン産生促進剤、ヒアルロナン分解抑制剤及びスキンケア剤を提供する。 【解決手段】ヒアルロナンを有効成分として含有する薬剤である。ヒアルロナンとしては-D-グルクロン酸-β-1,3-D-N-アセチルグルコサミン-β-1,4-を1単位とし、これを2個含む4糖(HA4)であることが好ましい。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2007/057741 WO2008129607A1 (ja) | 2007-04-06 | 2007-04-06 | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2007/057741 WO2008129607A1 (ja) | 2007-04-06 | 2007-04-06 | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008129607A1 true WO2008129607A1 (ja) | 2008-10-30 |
Family
ID=39875156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/057741 WO2008129607A1 (ja) | 2007-04-06 | 2007-04-06 | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008129607A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014227350A (ja) * | 2013-05-20 | 2014-12-08 | 株式会社テクノーブル | 化粧料 |
JP2018172375A (ja) * | 2017-03-31 | 2018-11-08 | ロート製薬株式会社 | ヒアルロン酸オリゴ糖含有組成物の製造方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62292710A (ja) * | 1986-06-12 | 1987-12-19 | Lion Corp | 皮膚化粧料 |
JPS6413008A (en) * | 1987-06-12 | 1989-01-17 | Unilever Nv | Skin treatment composition |
JPH01272511A (ja) * | 1988-04-21 | 1989-10-31 | Tokyo Sankei Kagaku:Kk | 化粧品用添加剤 |
JPH05504757A (ja) * | 1989-06-23 | 1993-07-22 | ヨー・アー・ベンキゼル・ゲーエムベーハー | スキンケア製剤 |
JP2003210134A (ja) * | 2002-01-18 | 2003-07-29 | Raku:Kk | ヒアルロン酸化合物の水溶液組成体 |
JP2007126453A (ja) * | 2005-10-07 | 2007-05-24 | Toshitsu Kagaku Kenkyusho:Kk | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
-
2007
- 2007-04-06 WO PCT/JP2007/057741 patent/WO2008129607A1/ja active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62292710A (ja) * | 1986-06-12 | 1987-12-19 | Lion Corp | 皮膚化粧料 |
JPS6413008A (en) * | 1987-06-12 | 1989-01-17 | Unilever Nv | Skin treatment composition |
JPH01272511A (ja) * | 1988-04-21 | 1989-10-31 | Tokyo Sankei Kagaku:Kk | 化粧品用添加剤 |
JPH05504757A (ja) * | 1989-06-23 | 1993-07-22 | ヨー・アー・ベンキゼル・ゲーエムベーハー | スキンケア製剤 |
JP2003210134A (ja) * | 2002-01-18 | 2003-07-29 | Raku:Kk | ヒアルロン酸化合物の水溶液組成体 |
JP2007126453A (ja) * | 2005-10-07 | 2007-05-24 | Toshitsu Kagaku Kenkyusho:Kk | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014227350A (ja) * | 2013-05-20 | 2014-12-08 | 株式会社テクノーブル | 化粧料 |
JP2018172375A (ja) * | 2017-03-31 | 2018-11-08 | ロート製薬株式会社 | ヒアルロン酸オリゴ糖含有組成物の製造方法 |
JP7285048B2 (ja) | 2017-03-31 | 2023-06-01 | ロート製薬株式会社 | ヒアルロン酸オリゴ糖含有組成物の製造方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009124266A3 (en) | Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof | |
WO2010045415A3 (en) | Topical nsaid compositions having sensate component | |
WO2010009111A3 (en) | A drug depot implantable within a synovial joint | |
IL206443A0 (en) | Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices | |
CA2963423A1 (en) | Device and method for delivery of a medicament | |
EP2605698A4 (en) | Central site photoplethysmography, medication administration, and safety | |
BR112012008823A2 (pt) | compostos que modulam receptor de androgênio | |
WO2010030728A3 (en) | Devices and systems for delivery of therapeutic agents to body lumens | |
WO2011076621A3 (de) | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten | |
WO2007085629A3 (en) | Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents | |
IL195316A0 (en) | Nanoparticles of chitosan and hyaluronan for the administration of active molecules | |
MY139913A (en) | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance | |
WO2010009140A3 (en) | Methods, systems and devices for administration of chlorine dioxide | |
WO2013067199A3 (en) | Subcutaneous delivery of polymer conjugates of therapeutic agents | |
WO2012087047A3 (en) | Percutaneous absorption preparation containing rivastigmine | |
WO2012022478A3 (en) | Filler composition comprising beta-glucans | |
EP2196206B8 (en) | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient | |
WO2008151040A3 (en) | Analgesic coated medical product | |
WO2009001209A8 (en) | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases | |
WO2011017306A3 (en) | Targeting therapeutic agents | |
WO2011076209A3 (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
PL1994926T3 (pl) | Preparaty walsartanu | |
MX2010004291A (es) | Producto de dispersion solida de farmacos basados en n-aril urea. | |
WO2007098967A3 (en) | Imidazole compounds having pharmaceutical activity towards the sigma receptor | |
WO2012099899A3 (en) | Topical dermatological compositions for the treatment of acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07741177 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07741177 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |